Ovarian cancer is the 8th most common carcinoma among women in the United States. While the precise cause of the disease are as of yet unknown, some known risk factors include family history of ovarian or breast cancer, history of fertility treatments, high number of total lifetime ovulations, age, personal history of breast carcinoma, history of endometriosis, obesity and HRT.
Before commencing ovarian cancer treatment it is important to understand what the suspicion is based on – whether it is due to elevated tumour marker levels, ascitic fluid cytology or ovarian biopsy results, ovarian biopsy, or abnormalities detected during a pelvic US scan.
Peritoneal carcinomatosis and ascites are the most common symptoms of ovarian carcinoma, appearing in over 90% of all cases. In approximately 20% of the cases peritoneal carcinomatosis is the only presentation of the disease (the tumour might not be detectable on US and MRI scans).
Diagnostics phase will include:
Length of diagnostics phase: 4 business days. It will take place at Assuta Medical Center’s specialized facilities, equipped with cutting edge technologies.
There are 2 options for ovarian cancer treatment in the unfortunate event the diagnosis is confirmed:
Your treating oncological gynecologist will determine which of these options is the most appropriate in your case.
The surgery that is performed in cases of ovarian carcinoma with carcinomatosis is a radical hysterectomy with bilateral salpingo-oophorectomy (TAH + BSO) and omentectomy.
Cost of the operation includes: